Amlodipine/celecoxib

Amlodipine/celecoxib

Combination of
Amlodipine	Calcium channel blocker
Celecoxib	Nonsteroidal anti-inflammatory drug (NSAID)
Clinical data
Trade names	Consensi
AHFS/Drugs.com	Monograph
License data	US DailyMed: Amlodipine besylate and celecoxib
Routes of administration	By mouth
ATC code	C08CA51 (WHO)
Legal status
Legal status	US: ℞-only[1]
Identifiers
KEGG	D11705

Amlodipine/celecoxib, sold under the brand name Consensi, is a fixed-dose combination medication used to treat both hypertension and osteoarthritis at the same time in adults.[1][2] It contains amlodipine, as the besilate, and celecoxib.[1] It is taken by mouth.[1]

The most common side effects include edema, abdominal pain, diarrhea, dyspepsia, flatulence, peripheral edema, accidental injury, dizziness, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, and rash.[1]

It was approved for medical use in the United States in May 2018.[3]

Medical uses

Amlodipine/celecoxib is indicated for use in adults for whom treatment with amlodipine for hypertension and celecoxib for osteoarthritis are appropriate.[1]

History

Amlodipine/celecoxib was approved for use in the United States in May 2018.[3]

References

1. "Consensi- amlodipine besylate and celecoxib tablet". DailyMed. 17 December 2019. Retrieved 14 May 2020.
2. Smith SM, Cooper-DeHoff RM (February 2019). "Fixed-Dose Combination Amlodipine/Celecoxib (Consensi) for Hypertension and Osteoarthritis". The American Journal of Medicine. 132 (2): 172–174. doi:10.1016/j.amjmed.2018.08.027. PMID 30240679. S2CID 52312672.
3. "Drug Approval Package: Consensi (amlodipine and celecoxib)". U.S. Food and Drug Administration (FDA). 29 November 2018. Retrieved 14 May 2020.